139 related articles for article (PubMed ID: 21254017)
21. Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.
Sasaki K; Margonis GA; Andreatos N; Wilson A; Weiss M; Wolfgang C; Sergentanis TN; Polychronidis G; He J; Pawlik TM
Br J Surg; 2017 Jun; 104(7):926-935. PubMed ID: 28266705
[TBL] [Abstract][Full Text] [Related]
22. Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases.
Pulitanò C; Arru M; Catena M; Guzzetti E; Vitali G; Ronzoni M; Venturini M; Villa E; Ferla G; Aldrighetti L
Ann Surg Oncol; 2008 Jun; 15(6):1661-9. PubMed ID: 18373123
[TBL] [Abstract][Full Text] [Related]
23. Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases.
van der Pool AE; Marsman HA; Verheij J; Ten Kate FJ; Eggermont AM; Ijzermans JN; Verhoef C
J Surg Oncol; 2012 Dec; 106(7):892-7. PubMed ID: 22552819
[TBL] [Abstract][Full Text] [Related]
24. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience.
Siperstein AE; Berber E; Ballem N; Parikh RT
Ann Surg; 2007 Oct; 246(4):559-65; discussion 565-7. PubMed ID: 17893492
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases.
Capussotti L; Muratore A; Mulas MM; Massucco P; Aglietta M
Br J Surg; 2006 Aug; 93(8):1001-6. PubMed ID: 16739103
[TBL] [Abstract][Full Text] [Related]
26. Repeat hepatectomy for recurrent colorectal metastases.
Wicherts DA; de Haas RJ; Salloum C; Andreani P; Pascal G; Sotirov D; Adam R; Castaing D; Azoulay D
Br J Surg; 2013 May; 100(6):808-18. PubMed ID: 23494765
[TBL] [Abstract][Full Text] [Related]
27. Portal triad clamping (TC) or hepatic vascular exclusion (VE) for major liver resection after prolonged neoadjuvant chemotherapy? A case-matched study in 60 patients.
Benoist S; Salabert AS; Penna C; Karoui M; Julié C; Rougier P; Nordlinger B
Surgery; 2006 Sep; 140(3):396-403. PubMed ID: 16934601
[TBL] [Abstract][Full Text] [Related]
28. Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases.
Maru DM; Kopetz S; Boonsirikamchai P; Agarwal A; Chun YS; Wang H; Abdalla EK; Kaur H; Charnsangavej C; Vauthey JN; Loyer EM
Am J Surg Pathol; 2010 Sep; 34(9):1287-94. PubMed ID: 20697255
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of optimal morphologic response to first-line chemotherapy in patients with colorectal liver metastases.
Yoshita H; Hosokawa A; Ueda A; Ando T; Kajiura S; Kato H; Kawabe H; Tomizawa G; Horikawa N; Yabuhita K; Note M; Sugiyama T
Digestion; 2014; 89(1):43-8. PubMed ID: 24458112
[TBL] [Abstract][Full Text] [Related]
30. Liver resection of colorectal metastases in elderly patients.
Adam R; Frilling A; Elias D; Laurent C; Ramos E; Capussotti L; Poston GJ; Wicherts DA; de Haas RJ;
Br J Surg; 2010 Mar; 97(3):366-76. PubMed ID: 20101645
[TBL] [Abstract][Full Text] [Related]
31. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases.
Kishi Y; Zorzi D; Contreras CM; Maru DM; Kopetz S; Ribero D; Motta M; Ravarino N; Risio M; Curley SA; Abdalla EK; Capussotti L; Vauthey JN
Ann Surg Oncol; 2010 Nov; 17(11):2870-6. PubMed ID: 20567921
[TBL] [Abstract][Full Text] [Related]
32. Extended preoperative chemotherapy, extent of liver resection and blood transfusion are predictive factors of liver failure following resection of colorectal liver metastasis.
Ribeiro HS; Costa WL; Diniz AL; Godoy AL; Herman P; Coudry RA; Begnami MD; Mello CA; Silva MJ; Zurstrassen CE; Coimbra FJ
Eur J Surg Oncol; 2013 Apr; 39(4):380-5. PubMed ID: 23351680
[TBL] [Abstract][Full Text] [Related]
33. [The safety of perioperative bevacizumab use].
Mariani P
J Chir (Paris); 2010 Jan; 147 Suppl 1():S12-7. PubMed ID: 20172200
[TBL] [Abstract][Full Text] [Related]
34. Recurrent disease four years after surgery and adjuvant chemotherapy.
Pozzo C; Barone C
Cancer Treat Rev; 2008; 34 Suppl 2():S8-11. PubMed ID: 19101406
[TBL] [Abstract][Full Text] [Related]
35. [A case of pathological complete response of metachronous multiple liver metastases from colorectal cancer after mFOLFOX+bevacizumab chemotherapy].
Otsuka S; Inagaki M; Nishie M; Hamano R; Tokunaga N; Takahashi K; Tsunemitsu Y; Miyoshi K; Iwakawa K; Takahashi M; Iwagak H
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2166-8. PubMed ID: 20037358
[TBL] [Abstract][Full Text] [Related]
36. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?
Adam R; Wicherts DA; de Haas RJ; Aloia T; Lévi F; Paule B; Guettier C; Kunstlinger F; Delvart V; Azoulay D; Castaing D
J Clin Oncol; 2008 Apr; 26(10):1635-41. PubMed ID: 18375892
[TBL] [Abstract][Full Text] [Related]
37. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival.
Shaw IM; Rees M; Welsh FK; Bygrave S; John TG
Br J Surg; 2006 Apr; 93(4):457-64. PubMed ID: 16555242
[TBL] [Abstract][Full Text] [Related]
38. Two-stage hepatectomy for multiple bilobar colorectal liver metastases.
Narita M; Oussoultzoglou E; Jaeck D; Fuchschuber P; Rosso E; Pessaux P; Marzano E; Bachellier P
Br J Surg; 2011 Oct; 98(10):1463-75. PubMed ID: 21710481
[TBL] [Abstract][Full Text] [Related]
39. Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM - Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor.
Martins J; Alexandrino H; Oliveira R; Cipriano MA; Falcão D; Ferreira L; Martins R; Serôdio M; Martins M; Tralhão JG; Prado e Castro L; Castro E Sousa F
Eur J Surg Oncol; 2016 May; 42(5):713-21. PubMed ID: 26972374
[TBL] [Abstract][Full Text] [Related]
40. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases.
Laurent C; Sa Cunha A; Couderc P; Rullier E; Saric J
Br J Surg; 2003 Sep; 90(9):1131-6. PubMed ID: 12945082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
